Evidence map›Paper›PMID 21807998›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2011

Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas.

Elisabetta Botti, Giulia Spallone, Francesca Moretti, Barbara Marinari, Valentina Pinetti, Sergio Galanti, Paolo D'Onorio De Meo, Francesca De Nicola, Federica Ganci, Tiziana Castrignanò and 7 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 109 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
109citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

109 citing papers in PubMed, 1 synthesis or guideline pooled it, 175 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. DNA Methylation Effects on Van der Woude Syndrome Phenotypic Variability.The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. ARHGAP29 promotes keratinocyte proliferation and migration in vitro and is dispensable for in vivo wound healing.Developmental dynamics : an official publication of the American Association of Anatomists · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

49 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 2 countries.

Elisabetta BottiDepartment of Dermatology, University of Rome Tor Vergata, 00133 Rome, Italy.
Giulia Spallone
Francesca Moretti
Barbara Marinari
Valentina Pinetti
Sergio Galanti
Paolo D'Onorio De Meo
Francesca De Nicola
Federica Ganci
Tiziana Castrignanò
Graziano Pesole
Sergio Chimenti
Luisa Guerrini
Maurizio Fanciulli
Giovanni Blandino
Michael Karin
Antonio Costanzo
University of Rome Tor Vergata · ITInstitute of Biomembranes, Bioenergetics and Molecular Biotechnologies · ITUniversity of California, San Diego · USUniversity of Milan · IT

Funding

REGULATION OF NFKB AND IKK BY PROINFLAMMATORY STIMULIR01AI043477 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KARIN, MICHAEL · 1998 to 2017
$7.4M
NF-kappaB and Mitochondrial Signals as Positive and Negative Regulators of InflammationR37AI043477 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Michael Karin · 2018 to 2026
$6.0M
NIAID NIH HHS AI043477NIAID NIH HHS R01 AI043477NIAID NIH HHS R37 AI043477
6 · The paper itself

Abstract

The transcription factor interferon regulatory factor 6 (IRF6) regulates craniofacial development and epidermal proliferation. We recently showed that IRF6 is a component of a regulatory feedback loop that controls the proliferative potential of epidermal cells. IRF6 is transcriptionally activated by p63 and induces its proteasome-mediated down-regulation, thereby limiting keratinocyte proliferative potential. We hypothesized that IRF6 may also be involved in skin carcinogenesis. Hence, we analyzed IRF6 expression in a large series of squamous cell carcinomas (SCCs) and found a strong down-regulation of IRF6 that correlated with tumor invasive and differentiation status. IRF6 down-regulation in SCC cell lines and primary tumors correlates with methylation on a CpG dinucleotide island located in its promoter region. To identify the molecular mechanisms regulating IRF6 potential tumor suppressive activity, we performed a genome-wide analysis by combining ChIP sequencing for IRF6 binding sites and gene expression profiling in primary human keratinocytes after siRNA-mediated IRF6 depletion. We observed dysregulation of cell cycle-related genes and genes involved in differentiation, cell adhesion, and cell-cell contact. Many of these genes were direct IRF6 targets. We also performed in vitro invasion assays showing that IRF6 down-regulation promotes invasive behavior and that reintroduction of IRF6 into SCC cells strongly inhibits cell growth. These results indicate a function for IRF6 in suppression of tumorigenesis in stratified epithelia.

Indexed as

Gene Expression Regulation, NeoplasticTumor Suppressor ProteinsCarcinoma, Squamous CellCell Physiological PhenomenaCell ProliferationDNA MethylationHumansInterferon Regulatory FactorsKeratinocytesNeoplasm InvasivenessSkin NeoplasmsTumor Cells, CulturedInterferon Regulatory FactorsIRF6 protein, humanTumor Suppressor Proteins

Identifiers

PMID21807998
PMCPMC3158164
OpenAlexW2154864587

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.